Literature DB >> 10644786

Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.

S Kuwabara1, K Ogawara, K Mizobuchi, M Koga, M Mori, T Hattori, N Yuki.   

Abstract

OBJECTIVES: To investigate the pathophysiology of selective absence of F waves and its relation with antiganglioside antibodies in Guillain-Barré syndrome (GBS). Some patients with GBS show the absence of F waves as an isolated conduction abnormality, which has been interpreted as demyelination in the proximal nerve segments.
METHODS: In 62 consecutive patients with GBS, sequential nerve conduction and F wave studies were reviewed, and antibodies against ganglioside GM1, GM1b, GD1a, GalNAc-GD1a, GD1b, and GQ1b were measured by an enzyme linked immunosorbent assay.
RESULTS: In the first electrophysiological studies, isolated absence of F waves was found in 12 (19%) patients. Sequential studies in 10 of these patients showed two electrophysiological sequel patterns; rapid restoration of F waves (six patients), and persistent absence of F waves with distal motor nerve degeneration (acute motor axonal neuropathy, four patients). None of the 10 patients showed evidence of demyelination in the proximal, intermediate, or distal nerve segments throughout the course. Of the 62 patients, IgG antibodies against GM1, GM1b, GalNAc-GD1a, or GD1b were significantly associated with the electrodiagnosis of acute motor axonal neuropathy, and patients with these antibodies more often had isolated absence of F waves than patients without them (11 of 36 (31%) v one of 26 (4%); p<0.01). Eleven of the 12 patients with isolated absence of F waves had positive serology for one or more antiganglioside antibodies.
CONCLUSIONS: In GBS with antiganglioside antibodies, isolated absence of F waves is a frequent conduction abnormality especially in the early phase of the disease, and may be caused by axonal dysfunction, such as physiological conduction block or axonal degeneration at the nerve roots.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644786      PMCID: PMC1736791          DOI: 10.1136/jnnp.68.2.191

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

Authors:  A A Ilyas; F A Mithen; M C Dalakas; Z W Chen; S D Cook
Journal:  J Neurol Sci       Date:  1992-01       Impact factor: 3.181

2.  Electrodiagnostic features of the Guillain-Barré syndrome: the relative sensitivity of different techniques.

Authors:  R K Olney; M J Aminoff
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

Review 3.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

4.  Patterns of recovery in the Guillain-Barre syndromes.

Authors:  T W Ho; C Y Li; D R Cornblath; C Y Gao; A K Asbury; J W Griffin; G M McKhann
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

5.  Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis.

Authors:  N Yuki; H Yoshino; S Sato; T Miyatake
Journal:  Neurology       Date:  1990-12       Impact factor: 9.910

6.  Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha.

Authors:  N Yuki; Y Tagawa; F Irie; Y Hirabayashi; S Handa
Journal:  J Neuroimmunol       Date:  1997-04       Impact factor: 3.478

7.  Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.

Authors:  T W Ho; B Mishu; C Y Li; C Y Gao; D R Cornblath; J W Griffin; A K Asbury; M J Blaser; G M McKhann
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

8.  Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group.

Authors:  L H Visser; F G Van der Meché; P A Van Doorn; J Meulstee; B C Jacobs; P G Oomes; R P Kleyweg; J Meulstee
Journal:  Brain       Date:  1995-08       Impact factor: 13.501

9.  Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome.

Authors:  A H Ropper; E F Wijdicks; B T Shahani
Journal:  Arch Neurol       Date:  1990-08

10.  Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.

Authors:  J H Rees; N A Gregson; R A Hughes
Journal:  Ann Neurol       Date:  1995-11       Impact factor: 10.422

View more
  12 in total

1.  Bickerstaff brainstem encephalitis after heat stroke.

Authors:  Akiyuki Uzawa; Masahiro Mori; Noriko Tamura; Hirokatsu Takahashi; Hiroyuki Hirasawa; Takamichi Hattori; Satoshi Kuwabara
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

2.  A rare mimic of acute stroke: rapidly progressing Miller-Fisher Syndrome to acute motor and sensory axonal neuropathy variant of Guillain-Barre Syndrome.

Authors:  Lennie Lynn Chua de Castillo; Jose Danilo Bengzon Diestro; Katrina Hannah Dizon Ignacio; Paul Matthew Dimaguila Pasco
Journal:  BMJ Case Rep       Date:  2019-03-31

3.  Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Kiichi Unoda; Kazushi Yamane; Yoshimitsu Doi; Shimon Ishida; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2016-06-08       Impact factor: 4.849

Review 4.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

Review 5.  Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.

Authors:  José Berciano; María J Sedano; Ana L Pelayo-Negro; Antonio García; Pedro Orizaola; Elena Gallardo; Miguel Lafarga; María T Berciano; Bart C Jacobs
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849

6.  Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.

Authors:  Velina Nedkova; Gerardo Gutiérrez-Gutiérrez; Francisco J Navacerrada-Barrero; José Berciano; Carlos Casasnovas
Journal:  Acta Neurol Belg       Date:  2021-02-18       Impact factor: 2.396

7.  c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy.

Authors:  Janina Hantke; Lucy Carty; Laura J Wagstaff; Mark Turmaine; Daniel K Wilton; Susanne Quintes; Martin Koltzenburg; Frank Baas; Rhona Mirsky; Kristján R Jessen
Journal:  Brain       Date:  2014-09-12       Impact factor: 13.501

8.  Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.

Authors:  Toshio Ariga; Masaru Kubota; Makoto Nakane; Kenji Oguro; Robert K Yu; Susumu Ando
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

9.  Clinical importance of F-waves as a prognostic factor in Guillain-Barré syndrome in children.

Authors:  Eung-Bin Lee; Yun Young Lee; Jae Min Lee; Su Min Son; Su-Kyeong Hwang; Soonhak Kwon; Sae Yoon Kim
Journal:  Korean J Pediatr       Date:  2016-06-30

10.  Atypical Electrophysiological Findings in a Patient with Acute Motor and Sensory Axonal Neuropathy.

Authors:  Viviana Versace; Stefania Campostrini; Frediano Tezzon; Sara Martignago; Markus Kofler; Leopold Saltuari; Luca Sebastianelli; Raffaele Nardone
Journal:  Front Neurol       Date:  2017-11-08       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.